TrialLiver international : official journal of the International Association for the Study of the Liver2022

Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.

Paolo Ventura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.